United States · FDA National Drug Code directory

AMLODIPINE BESYLATE 2.5 mg

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82804-969_6313edc5-d2d5-44a1-a06f-7f7829c870d2
Product NDC
82804-969
Form
TABLET
Composition / generic term
AMLODIPINE BESYLATE
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20211001
Source listing expiry
20261231

Source-listed ingredients

  • AMLODIPINE BESYLATE — 2.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (82804-969-00) · 82804-969-00
  • 1000 TABLET in 1 BOTTLE (82804-969-11) · 82804-969-11
  • 30 TABLET in 1 BOTTLE (82804-969-30) · 82804-969-30
  • 500 TABLET in 1 BOTTLE (82804-969-55) · 82804-969-55
  • 60 TABLET in 1 BOTTLE (82804-969-60) · 82804-969-60
  • 120 TABLET in 1 BOTTLE (82804-969-72) · 82804-969-72
  • 90 TABLET in 1 BOTTLE (82804-969-90) · 82804-969-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →